Viewing Study NCT03705403


Ignite Creation Date: 2025-12-24 @ 7:45 PM
Ignite Modification Date: 2026-02-23 @ 12:19 PM
Study NCT ID: NCT03705403
Status: TERMINATED
Last Update Posted: 2025-01-30
First Post: 2018-06-27
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: IMMUNOtherapy and Stereotactic ABlative Radiotherapy (IMMUNOSABR) a Phase II Study
Sponsor: Maastricht University Medical Center
Organization:

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None NSCLC Stage IV View
None Metastatic Disease View
Keywords: